The Path to Optimal Black Maternal Heart Health: Comparing Two CVD Risk Reduction Interventions (Change of HEART)
1 other identifier
interventional
432
1 country
1
Brief Summary
The overarching goal of our proposal is to reduce disparities in perinatal cardiovascular disease risk factors among Black women utilizing a community-driven, social ecological framework.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2023
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 6, 2022
CompletedFirst Posted
Study publicly available on registry
August 12, 2022
CompletedStudy Start
First participant enrolled
January 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 10, 2028
December 11, 2025
December 1, 2025
4.5 years
July 6, 2022
December 4, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Change in blood pressure at 6-weeks postpartum.
Blood pressure will be measured at each time point on the upper arm three times at one-minute intervals after five minutes of quiet sitting. The investigators will use the validated Omron HEM-907XL and the appropriate size cuff. The investigators will average the three measures for analysis.
At baseline and 6-weeks postpartum
Change in blood pressure at 12-months postpartum.
Blood pressure will be measured at each time point on the upper arm three times at one-minute intervals after five minutes of quiet sitting. The investigators will use the validated Omron HEM-907XL and the appropriate size cuff. The investigators will average the three measures for analysis.
At baseline and 12-months postpartum
Change in body weight at 6-weeks postpartum.
Body weight will be measured in duplicate and recorded to the nearest 0.1kg using calibrated SECA scales at each time point.
At baseline and 6-weeks postpartum
Change in body weight at 12-months postpartum.
Body weight will be measured in duplicate and recorded to the nearest 0.1kg using calibrated SECA scales at each time point.
At baseline and 12-months postpartum
Secondary Outcomes (23)
Change in emotional support at 6-weeks postpartum.
At baseline and 6-weeks postpartum
Change in emotional support at 12-months postpartum.
At baseline and 12-months postpartum
Change in informational support at 6-weeks postpartum.
At baseline and 6-weeks postpartum
Change in informational support at 12-months postpartum.
At baseline and 12-months postpartum
Change in Perinatal Mood and Anxiety Disorders (PMADs) at 6-weeks postpartum.
At baseline and 6-weeks postpartum
- +18 more secondary outcomes
Study Arms (2)
Change of Heart (COH)
ACTIVE COMPARATORIncorporates two, evidence-based individual-level interventions (home blood pressure telemonitoring coupled with the interactive obesity treatment approach, that includes nutrition and physical activity text messages with tailored feedback) and an institutional-level intervention (anti-racism training of providers and staff along with patient feedback to inform respectful care).
Change of Heart Plus (COH+)
EXPERIMENTALIncludes all components of COH plus the addition of interpersonal support for Black women by Black women (community doula care, mental health services, and lactation support).
Interventions
Includes all components of COH plus interpersonal support for Black women by Black women (community doula care, mental health services, and lactation support).
Eligibility Criteria
You may qualify if:
- age ≥18 years
- baseline BMI ≥30 kg/m2 and/or diagnosis of HTN (≥130/80 x 2)
- gestational age \<24 weeks by last menstrual period
- smartphone ownership
- self-identification as Black or African American
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Temple Universitylead
- Patient-Centered Outcomes Research Institutecollaborator
Study Sites (1)
Temple University/Temple Health
Philadelphia, Pennsylvania, 19140, United States
Related Publications (1)
Wycoff KL, Coleman JG, Santoro CM, Zullig LL, Darden N, Holland PM, Cruice JF, Mitchell S, Smith M, McNeil SJ, Herring SJ. Multilevel Community Engagement to Inform a Randomized Clinical Trial. Obstet Gynecol. 2023 Oct 1;142(4):929-939. doi: 10.1097/AOG.0000000000005344. Epub 2023 Sep 7.
PMID: 37734093DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sharon J Herring, MD, MPH
Temple University, Philadelphia, Pennsylvania, United States, 19140
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2022
First Posted
August 12, 2022
Study Start
January 24, 2023
Primary Completion (Estimated)
July 15, 2027
Study Completion (Estimated)
December 10, 2028
Last Updated
December 11, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- 8/10/2027
Descriptions of the study dataset, including codebooks and documentation of the programming code used for creating the final study population, variable definitions, and descriptive and outcome analyses will be provided at the end of the final funding year. The investigators will make these materials, as well as the final dataset, available via the Inter-university Consortium for Political and Social Research (ICPSR, https://www.icpsr.umich.edu/web/pages/) of which Temple University is a member.